Session «Early-Onset Cancer: Biological and Clinical Features»
The session is organized by the EPOY Consortium and hold as part of the VIII INTERNATIONAL FORUM OF ONCOLOGY AND RADIOTHERAPY.
The session “Early-Onset Cancer: Biological and Clinical Features” focuses on the growing global problem of cancers diagnosed in adults under the age of 45. The main goal of the session is to discuss the latest advances in understanding early-onset cancers occurrence, pathogenesis and the specifics of their treatment. The event promotes new collaborations and outlines future directions for research and clinical care for young adults.
Date: September 15-19, 2025.
Chairs
M.D., Dr. Sci. (Med.), Professor, Full Member of the Russian Academy of Sciences, Director of Cancer Research Institute, Tomsk NRMC, Tomsk, Russia
M.D., Dr. Sci. (Med.), Head of Department of Head and Neck Tumors and Microsurgery, P. Hertsen MORI – Branch of the NMRRC, Moscow, Russia
Ph.D., Dr. Sci. (Biology), Head of the Laboratory of Cancer Progression Biology, Tomsk NRMC, Tomsk; Head of Single Cell Biology Laboratory, RUDN University, Moscow, Russia
Speakers
Ph.D., Deputy Director of the Sanford Stem Cell Fitness and Space Medicine Center, Professor of Cellular and Molecular Medicine and Bioengineering, UC, San Diego, USA
M.D., Ph.D., Principal Investigator at the Institute of Biomedical Research, USAL, Salamanca; Chief of Surgery Department, Vithas Arturo Soria Hospital, Madrid, Spain
M.D., Dr. Sci. (Med.), Professor, Leading Researcher in Oncology, Botkin Hospital, Professor of the Department of Oncology and X-ray Radiology named after V.P. Kharchenko, RUDN University, Moscow, Russia
M.D., Senior Consultant and Director of Head and Neck Surgery at Sparsh Hospitals, Bangalore, India
Ph.D., Researcher of the Laboratory of Cancer Progression Biology, Cancer Research Institute, Tomsk NRMC, Tomsk, Russia
M.D., Oncologist of the Department of Antitumor Drug Therapy No. 2, N.N. Blokhin NMRCO, Moscow, Russia
M.D., Pediatric Oncologist, Senior Researcher of the Children’s Oncology Department No. 1, N.N. Blokhin NMRCO, Moscow, Russia
The session is organized by the EPOY Consortium and hold as part of the VII INTERNATIONAL FORUM OF ONCOLOGY AND RADIOTHERAPY.
The session “Early-Onset Cancer: Biological and Clinical Features” focuses on the growing global problem of cancers diagnosed in adults under the age of 45. The issue of rejuvenating cancer is much broader than early-onset oral cancer and encompasses other locations. Therefore, a decision was made to expand the consortium’s thematic scope and conduct scientific research and events on the issue of early-onset cancer in general.
Date: September 18, 2024.
The session is organized by the EPOY Consortium and hold as part of the VI INTERNATIONAL FORUM OF ONCOLOGY AND RADIOTHERAPY.
The session “Early-Onset Oral Cancer: Biological and Clinical Features” explores the rising incidence of the disease (occurring in individuals under 45 years old), focusing on its distinct biological characteristics, clinical behavior, and potential etiological factors. The aim is to attract the attention of oncologists to the problem, highlight modern achievements in this field, discuss the scientific results obtained within the consortium, formulate new ideas and initiate new research.
Date: September 12, 2023.
The Workshop is organized by the EPOY Consortium and based at the N.N. Blokhin Cancer Research Center.
The session “Early-Onset Oral Cancer: Biological and Clinical Features” explores the rising incidence of the disease (occurring in individuals under 45 years old), focusing on its distinct biological characteristics, clinical behavior, and potential etiological factors. The aim is to attract the attention of oncologists to the problem, highlight modern achievements in this field, discuss the scientific results obtained within the consortium, formulate new ideas and initiate new research.
Date: November 23, 2022.
Venue: Russia, Moscow, NN Blokhin NMRCO, Kashirskoe shosse, 23.